Spots Global Cancer Trial Database for gemcitabine, cisplatin
Every month we try and update this database with for gemcitabine, cisplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| GNT Induction Treatment in Locally Advanced NPC | NCT06026878 | Nasopharyngeal ... | gemcitabine,nim... gemcitabine, ci... | 18 Years - 75 Years | Air Force Military Medical University, China | |
| Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | NCT00173888 | Non-small Cell ... | Docetaxel, Cisp... Gemcitabine, Ci... | 18 Years - 75 Years | National Taiwan University Hospital | |
| ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) | NCT02546934 | Breast Cancer | ABX, cisplatin Gemcitabine, Ci... | 18 Years - 70 Years | Fudan University | |
| Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma | NCT00617656 | Non Small Cell ... BRCA1 Mutation | Cisplatin, Doce... Gemcitabine, Ci... Docetaxel, Cisp... Docetaxel | 18 Years - | Spanish Lung Cancer Group | |
| Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer | NCT01096745 | Metastatic Bili... Locally Advance... | Gemcitabine, Ci... S-1, Cisplatin | 20 Years - | Gyeongsang National University Hospital | |
| Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer | NCT02074189 | Bladder Cancer | Gemcitabine, Ci... | 18 Years - | Southwest Hospital, China | |
| Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer | NCT02716961 | Bladder Cancer Gemcitabine and... Epirubicin Inst... Recurrence Prognosis | Gemcitabine, ci... | 18 Years - 70 Years | The First Affiliated Hospital with Nanjing Medical University | |
| ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) | NCT02546934 | Breast Cancer | ABX, cisplatin Gemcitabine, Ci... | 18 Years - 70 Years | Fudan University | |
| Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer | NCT02716961 | Bladder Cancer Gemcitabine and... Epirubicin Inst... Recurrence Prognosis | Gemcitabine, ci... | 18 Years - 70 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer | NCT02074189 | Bladder Cancer | Gemcitabine, Ci... | 18 Years - | Southwest Hospital, China | |
| Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract | NCT03051373 | Carcinoma, Tran... | nanoparticle al... Gemcitabine, ci... | 18 Years - 70 Years | Chinese PLA General Hospital | |
| Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma | NCT00617656 | Non Small Cell ... BRCA1 Mutation | Cisplatin, Doce... Gemcitabine, Ci... Docetaxel, Cisp... Docetaxel | 18 Years - | Spanish Lung Cancer Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
